(Q34526979)

2 August 2017

title

Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial (English)

1 reference

multicenter clinical trial

2 August 2017

main subject

0 references

multiple sclerosis

0 references

relapsing-remitting multiple sclerosis

0 references

0 references

1

Luca Massacesi

1 reference

2 August 2017

Irene Tramacere

2

0 references

Maria Donata Benedetti

object named as

Maria Donata Benedetti

5

0 references

Gioacchino Tedeschi

10

object named as

Gioacchino Tedeschi

1 reference

2 August 2017

Salvatore Amoroso

3

1 reference

2 August 2017

Mario A Battaglia

4

1 reference

2 August 2017

Graziella Filippini

6

1 reference

2 August 2017

Loredana La Mantia

7

1 reference

2 August 2017

Anna Repice

8

1 reference

2 August 2017

Alessandra Solari

9

1 reference

2 August 2017

Clara Milanese

11

1 reference

2 August 2017

language of work or name

English

0 references

publication date

17 November 2014

1 reference

2 August 2017

1 reference

2 August 2017

volume

9

1 reference

2 August 2017

issue

11

1 reference

2 August 2017

page(s)

e113371

1 reference

Creative Commons Attribution 4.0 International

2 August 2017

copyright license

start time

17 November 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234663

Azathioprine for multiple sclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234663

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234663

Interferons in relapsing remitting multiple sclerosis: a systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234663

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234663

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234663

Disease-modifying drugs for multiple sclerosis: a rapid and systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234663

Validation of Italian multiple sclerosis quality of life 54 questionnaire

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234663

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234663

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234663

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234663

A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234663

The efficacy of azathioprine in relapsing-remitting multiple sclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234663

Overview of azathioprine treatment in multiple sclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4234663

Azathioprine and interferon beta-1b treatment in relapsing-remitting multiple sclerosis

7 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113371

Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113371

Sample size calculations in randomised trials: mandatory and mystical

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113371

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113371

Multiple imputation of missing blood pressure covariates in survival analysis

21 January 2018

1 reference

12 December 2020

Efficacy of azathioprine on multiple sclerosis new brain lesions evaluated using magnetic resonance imaging

1 reference

12 December 2020

Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Superiority trials, noninferiority trials, and prisoners of the 2-sided null hypothesis

1 reference

12 December 2020

Double-masked trial of azathioprine in multiple sclerosis. British and Dutch Multiple Sclerosis Azathioprine Trial Group

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

A double blind study on azathioprine efficacy in multiple sclerosis: final report

1 reference

12 December 2020

Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group

1 reference

12 December 2020

New treatments and azathioprine in multiple sclerosis

1 reference

12 December 2020

Lesion load quantification in serial MR of early relapsing multiple sclerosis patients in azathioprine treatment. A retrospective study

1 reference

12 December 2020

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0113371

Identifiers

DOI

1 reference

2 August 2017

0 references

1 reference

2 August 2017

1 reference